DavidDuaneHurdMD

Oncology • Winston Salem, NC

Professor, Internal Medicine, Bowman Gray School of Medicine of Wake Forest Univ

Join to view full profile

Dr. Hurd is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hurd's full profile

Already have an account?

Office
S Hawthorne Rd
Winston Salem, NC 27157
Phone+1 336-716-2255

Education & Training

University of MinnesotaResidency, Internal Medicine, 1976 - 1978
University of MinnesotaInternship, Internal Medicine, 1974 - 1975
University of Illinois College of MedicineClass of 1974

Certifications & Licensure

NC State Medical License 1989 - 2025
MN State Medical License 1975 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Top MD Consumers Checkbook

Clinical Trials

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer Start of enrollment: 1996 Jun 01
Completed
Phase 3
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer Start of enrollment: 1993 Feb 01
Completed
Phase 2
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
Completed
Phase 3
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy Start of enrollment: 2008 Aug 01
Completed
Phase 2
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) Start of enrollment: 2009 Apr 01
Completed
Phase 2
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma Start of enrollment: 2010 Sep 01
Completed
Phase 2
Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma Start of enrollment: 2011 Apr 28
Completed
Phase 1
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Oct 01
Active, not recruiting
Phase 3
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Active, not recruiting
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen Start of enrollment: 2001 May 21
Recruiting
Join now to see all

Publications & Presentations

PubMed

A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Todd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, Fei Wan, David D Hurd
Haematologica. 2024-03-01
3 citations
A pilot study of lenalidomide maintenance therapy after autologous transplantation in relapsed or refractory classical Hodgkin lymphoma
Lauren Shea, Marcus Watkins, Fei Wan, Amanda F. Cashen, Nina D. Wagner-Johnston
Biology of Blood and Marrow Transplantation. 2020-12-01
18 citations
Bortezomib Consolidation or Maintenance Following Immunochemotherapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: CALGB/Alliance 50403.
Lawrence D. Kaplan, Matthew J. Maurer, Wendy Stock, Nancy L. Bartlett, Noreen Fulton
American Journal of Hematology. 2020-03-13

Lectures

Bortezomib Maintenance (BM) or Consolidation (BC) Following Aggressive Immunochemotherapy and Autologous Stem Cell Transplant (ASCT) for Untreated Mantle Cell Lymphoma...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Vaccination Mandates for Healthcare Workers: Updates from 4 StatesNovember 2nd, 2021
Empire State Weekly: Federal Judge Blocks Health Care Vaccine MandateOctober 15th, 2021
Federal Judge: Religious Vaccine Exemption Stays for New York Health Care WorkersOctober 12th, 2021
Join now to see all

Grant Support

Clinical Trial: Selenium And Vitamin E Cancer Prevention Trial (SELECT)National Center For Research Resources2008–2010
Cancer And Leukemia Group BNational Cancer Institute1999–2008
Selenium And Vitamin E Cancer Prevention Trial (SELECT)National Center For Research Resources2007
Detection Of MDS Using Fish In Pretransplant SamplesNational Cancer Institute2001–2002
Cancer And Leukemia Group BNational Cancer Institute1998

Professional Memberships

American Society of Clinical Oncology - ASCO
Member